Literature DB >> 8677926

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials.

S J Veldhuyzen van Zanten1, C Cleary, N J Talley, T C Peterson, O Nyrén, L A Bradley, M Verlinden, G N Tytgat.   

Abstract

OBJECTIVES: To evaluate drug treatment of functional dyspepsia (including Helicobacter pylori) and provide guidelines for future trials based on a critical systematic overview of published studies.
METHODS: Data sources were a Medline search for articles published in English going back to 1966 and a manual search of four GI journals going back to 1980. Original randomized, double-blind, placebo-controlled trials were selected that enrolled at least 20 patients. Using a standardized, pretested data extraction form, studies were evaluated independently by two observers for study design, outcome measures, and results.
RESULTS: Fifty two eligible studies were evaluated. Many studies suffered from important weaknesses in study design and execution. Only five studies used previously validated outcome measures.
CONCLUSIONS: Because of suboptimal design and/or unclear presentation of the data, none of the trials provided unequivocal evidence that there is efficacious therapy for the treatment of functional dyspepsia.

Entities:  

Mesh:

Year:  1996        PMID: 8677926

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  48 in total

1.  Design of treatment trials for functional gastrointestinal disorders.

Authors:  S J Veldhuyzen van Zanten; N J Talley; P Bytzer; K B Klein; P J Whorwell; A R Zinsmeister
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Treating non-ulcer dyspepsia and H pylori.

Authors:  S J van Zanten
Journal:  BMJ       Date:  2000-09-16

3.  Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis.

Authors:  J P Guo; A H Maurer; R S Fisher; H P Parkman
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

4.  Nonulcer Dyspepsia.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

5.  CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.

Authors:  David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman
Journal:  BMJ       Date:  2010-03-23

Review 6.  Functional gastroduodenal disorders.

Authors:  N J Talley; V Stanghellini; R C Heading; K L Koch; J R Malagelada; G N Tytgat
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 7.  New therapies for functional bowel diseases.

Authors:  B Coulie; M Camilleri
Journal:  Curr Gastroenterol Rep       Date:  2000-10

8.  All Roads Lead to Rome: Update on Rome III Criteria and New Treatment Options.

Authors:  David Q Shih; Lola Y Kwan
Journal:  Gastroenterol Rep       Date:  2007       Impact factor: 3.651

9.  Loss of sympathetic coordination appears to delay gastrointestinal transit in patients with spinal cord injury.

Authors:  Chih-Yen Chen; Tien-Yow Chuang; Yun-An Tsai; Ho-Chang Tai; Ching-Liang Lu; Lih-Jiun Kang; Rei-Hwa Lu; Full-Young Chang; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

10.  The EQ-5D (Euroqol) is a valid generic instrument for measuring quality of life in patients with dyspepsia.

Authors:  Sanjiv Mahadeva; Hwee-Lin Wee; Khean-Lee Goh; Julian Thumboo
Journal:  BMC Gastroenterol       Date:  2009-03-12       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.